- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Wave Life Sciences Ltd (WVE)
Track the Wave Life Sciences Ltd share price today and view real-time WVE share price data, including charts, technicals, and key financials. View the WVE premarket stock price ahead of the market session or assess the after hours quote. Explore WVE stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Wave Life Sciences Ltd Stock Price Today?
The Wave Life Sciences Ltd stock price today is 3.450.
What Is the Stock Symbol for Wave Life Sciences Ltd?
The stock symbol for Wave Life Sciences Ltd is ""WVE.""
What Stock Exchange Does Wave Life Sciences Ltd Trade On?
Wave Life Sciences Ltd is listed and trades on the NASDAQ stock exchange.
Is Wave Life Sciences Ltd a Good Stock to Buy?
Determining whether Wave Life Sciences Ltd or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WVE quote. (ISIN: US94352A1043)
What Is the Wave Life Sciences Ltd Stock Price Today?
The Wave Life Sciences Ltd stock price today is 3.450.
What Is the Stock Symbol for Wave Life Sciences Ltd?
The stock symbol for Wave Life Sciences Ltd is ""WVE.""
What Stock Exchange Does Wave Life Sciences Ltd Trade On?
Wave Life Sciences Ltd is listed and trades on the NASDAQ stock exchange.
Is Wave Life Sciences Ltd a Good Stock to Buy?
Determining whether Wave Life Sciences Ltd or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WVE quote. (ISIN: US94352A1043)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.235
3.550
52 wk Range
3.040
21.730
WVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.2353.550
52 wk Range
3.04021.730
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
WVE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
17.684
Upside
+412.59%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form 8K WAVE LIFE SCIENCES For: 27 October- Investing.com
- Form 8K WAVE LIFE SCIENCES For: 27 October
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
19 Buy
2 Hold
0 Sell
Ratings:
21 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 17.684
(+412.59% Upside)
Wave Life Sciences Ltd SWOT Analysis
RNA Editing Pionee | Wave Life Sciences leads in RNA editing oligonucleotides, targeting genetic diseases with a diverse pipeline and promising early-stage results in key programs |
AATD Breakthrough | Explore WVE-006's potential for monthly dosing in alpha-1 antitrypsin deficiency, with favorable regulatory pathways and encouraging safety data |
Obesity Market Entry | Delve into Wave's unique INHBE-targeting approach for obesity treatment, offering potential yearly dosing and differentiation in a competitive landscape |
Financial Outlook | Analyst price targets range from $9 to $36, with a consensus "Strong Buy" recommendation despite near-term profitability challenges |
Wave Life Sciences Ltd Earnings Call Summary for Q3/2026
- Wave Life Sciences Q3 2026 revenue hit $13.2M, beating estimates by 82% on GSK collaboration income; EPS of -$0.30 also topped forecasts.
- Company holds $431M in cash through Q3 2028, expects $12M GSK milestone in Q4 2026; net loss widened to $61.9M from $53.9M year-over-year.
- Q4 data expected for obesity drug WVE-007 (600mg dose) and alpha-1 antitrypsin candidate WVE-006, targeting single registrational trial path.
- Stock rose 1.09% to $3.245 pre-market but trades near 52-week low of $3.04; analyst price targets range from $10-$42 suggesting upside potential.
- CEO Bolno highlighted WVE-007's differentiation from GLP-1s via fat loss without muscle loss; GSK partnership validates oligonucleotide platform.
Last Updated: 28/10/2026, 12:52 am
Read Full TranscriptEarnings
Latest Release
27/10/2026
EPS / Forecast
-0.30 / -0.32
Revenue / Forecast
13.16M / 7.24M
Compare WVE to Peers and Sector
Metrics to compare | WVE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWVEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.4x | −5.7x | −0.3x | |
PEG Ratio | 0.11 | 0.37 | 0.00 | |
Price/Book | 1.5x | 1.6x | 2.6x | |
Price / LTM Sales | 10.4x | 33.9x | 2.9x | |
Upside (Analyst Target) | - | 87.0% | 64.0% | |
Fair Value Upside | Unlock | −9.2% | 9.7% | Unlock |
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington’s disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Wave Life Sciences Ltd (WVE) Stock Price Today?
The Wave Life Sciences Ltd stock price today is 3.450 USD.
What Stock Exchange Does Wave Life Sciences Ltd Trade On?
Wave Life Sciences Ltd is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Wave Life Sciences Ltd?
The stock symbol for Wave Life Sciences Ltd is "WVE."
What Is the Wave Life Sciences Ltd Market Cap?
As of today, Wave Life Sciences Ltd market cap is 679.820M USD.
What Is Wave Life Sciences Ltd's Earnings Per Share (TTM)?
The Wave Life Sciences Ltd EPS (TTM) is -1.08.
From a Technical Analysis Perspective, Is WVE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Wave Life Sciences Ltd Stock Split?
Wave Life Sciences Ltd has split 0 times.
How Many Employees Does Wave Life Sciences Ltd Have?
Wave Life Sciences Ltd has 317 employees.
What is the current trading status of Wave Life Sciences Ltd (WVE)?
As of 28/10/2026, Wave Life Sciences Ltd (WVE) is trading at a price of 3.450 USD, with a previous close of 3.450 USD. The stock has fluctuated within a day range of 3.235 USD to 3.550 USD, while its 52-week range spans from 3.040 USD to 21.730 USD.
What Is Wave Life Sciences Ltd (WVE) Price Target According to Analysts?
The average 12-month price target for Wave Life Sciences Ltd is 17.684 USD, with a high estimate of 42 USD and a low estimate of 10 USD. 19 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +412.59% Upside potential.
What Is the WVE Premarket Price?
WVE's last pre-market stock price is 3.520 USD. The pre-market share volume is 70,030.000, and the stock has decreased by 0.310, or 9.660%.
What Is the WVE After Hours Price?
WVE's last after hours stock price is 3.500 USD, the stock has decreased by 0.050, or 1.450%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.